Table 4.
Experimental groups | Renal MDA (nmol/g protein) | Renal GSH (nmol/mg protein) | Renal CAT (u/mg protein) |
---|---|---|---|
Group 1 | 0.84 ± 0.202 | 0.681 ± 0.174 | 68.47 ± 14.58 |
Group 2 | 3.65 ± 0.581 * | 0.293 ± 0.053 * | 11.99 ± 4.4 * |
Group 3 | 2.628 ± 0.465 * | 0.274 ± 0.061 * | 18.25 ± 3.41 * |
Group 4 | 2.185 ± 0.596 * | 0.203 ± 0.054 * | 34.88 ± 8.49 * # |
Group 5 | 2.905 ± 0.419 * | 0.314 ± 0.084 * | 26.85 ± 6.15 * |
Group 6 | 1.921 ± 0.305 * # | 0.261 ± 0.073 * | 53.81 ± 8.26 # |
Values represented as mean ±SEM. * Significant change in comparison with control At P < 0.05. # Significant change in comparison with gentamicin only treated at P < 0.05. group 1 as control; group 2 received daily GS (100 mg/kg Ip); group 3 received oxygen 2 hr daily for 2 days and then received daily GS; group 4 received oxygen 4 hr daily for 2 days and then received daily GS; group 5 received oxygen 4 hr daily for 4 days and then received daily GS and group 6 received oxygen 2 hr daily for 2 days and then during daily injection GS received 2 hr oxygen before injection